In this context, investigating the expression of both FBN1 and the novel glucogenic hormone asprosin in human ovarian tissues will enhance our understanding of the underlying molecular mechanisms implicated in ovarian cancer, as well as the regulation of its tumour microenvironment (20). The gene discussed is FBN1; the disease is ovarian cancer.